Loncar China BioPharma ETF — new fund registration

ETF Series Solutions registered 1 new fund series on Form 485APOS, filed 2018-05-25. Featured series: Loncar China BioPharma ETF.

Registration

Registrant / trust: ETF Series Solutions
CIK: 0001540305
Form: 485APOS
Filed: 2018-05-25
State of incorporation: DE
Accession: 0000894189-18-003080
Reported net assets: $4.2M

Series & classes (1)

Series	Class	Ticker	New
Loncar China BioPharma ETF	Loncar China BioPharma ETF	—	Yes

Fees (from the effective prospectus)

12b-1 fee: 0.00%
Gross expense ratio: 0.79%
Management fee: 0.79%
Other expenses: 0.00%

Investment objective

The Loncar China BioPharma ETF (the Fund) seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the Index).

Advisers

Other filings by this registrant (15)

More